| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5574452 | Journal of Stroke and Cerebrovascular Diseases | 2017 | 13 Pages |
Abstract
Plasmin treatment of the occluded middle cerebral artery within 9 hours of stroke onset was well tolerated and did notincrease adverse outcomes; however, successful recanalization was achieved in only a limited number of patients.
Related Topics
Health Sciences
Medicine and Dentistry
Clinical Neurology
Authors
Peter J. MBBS, MMed, Bernard FRACP, Miroslav MD, PhD, Marc MD, PhD, Victor MD, Kecia L. BS, Jeffrey L. MD, FAHA, FAAN, FANA, Plasmin Trial Investigators Plasmin Trial Investigators,